Systemic treatment of advanced esophageal squamous cell carcinoma: chemotherapy, molecular-targeting therapy and immunotherapy
Author:
Affiliation:
1. Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
2. Department of Medicine, Keio University Graduate School of Medicine, Tokyo, Japan
Publisher
Oxford University Press (OUP)
Subject
Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine
Link
http://academic.oup.com/jjco/article-pdf/49/5/412/28543970/hyz034.pdf
Reference68 articles.
1. Global cancer statistics, 2012;Torre;CA Cancer J Clin,2015
2. Trends in esophageal cancer survival in United States adults from 1973 to 2009: A SEER database analysis;Njei;J Gastroenterol Hepatol,2016
3. Cisplatin and 5-fluorouracil in the primary management of squamous esophageal cancer;Kies;Cancer,1987
4. Preoperative chemotherapy, surgical resection, and selective postoperative therapy for squamous cell carcinoma of the esophagus;Hilgenberg;Ann Thorac Surg,1988
5. Prolonged chemotherapy for localised squamous carcinoma of the oesophagus;Ajani;Eur J Cancer,1992
Cited by 116 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Tumor‐Resident Microbiota‐Based Risk Model Predicts Neoadjuvant Therapy Response of Locally Advanced Esophageal Squamous Cell Carcinoma Patients;Advanced Science;2024-09-13
2. Efficacy and safety evaluation of first-line systemic treatments for unresectable esophageal squamous cell carcinoma: a network meta-analysis;Frontiers in Oncology;2024-09-09
3. CAFs-derived Exosomal miR-889-3p Might Repress M1 Macrophage Polarization to Boost ESCC Development by Regulating STAT1;Cell Biochemistry and Biophysics;2024-09-05
4. Synaptotagmin 13 Could Drive the Progression of Esophageal Squamous Cell Carcinoma Through Upregulating ACRV1;DNA and Cell Biology;2024-07-24
5. Sirtuin1 (sirt1) regulates the glycolysis pathway and decreases cisplatin chemotherapeutic sensitivity to esophageal squamous cell carcinoma;Cancer Biology & Therapy;2024-06-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3